In collaboration with, ALS Inc. and Northwestern Reproductive Genetics, Inc., we offer PGD testing for Aneuploidy and Gender Choice.
Patient Selection
PGD from ALS, Inc. should be recommended for:
All women ...
- In their mid-30s and older
- Suffering from repeat IVF failures
- Suffering from repeat miscarriage
All families ...
- At risk for gender-related genetic disorders
- Seeking gender choice
Test Recommendation
Two types of PGD tests are currently available from ALS, Inc.:
- Aneuploidy Testing for chromosomes 13, 16, 18, 21, 22, X &Y using FISH probes
- Gender Selection for chromosomes X &Y using FISH probes or PCR-Based DNA amplification
Procedure
Your PGD test should be fully coordinated between our own laboratory staff and the clinic where you are being managed. Please make sure that detailed arrangements have been made in advance. That facility should have basic micro-manipulation tools. If they don't, we can recommend another facility that has the proper instruments for your biopsy.
Up to 8 embryos can be biopsied for each patient, and each embryo should be in the 6 to 8 blastomere stage. Of these, 1 or 2 blastomeres will be biopsied. Additional embryos per patient require prior authorization. The results will be available and communicated to you within 2 days.
Genetic Counseling
Counseling is available and can be arranged upon prior request.
Please 
All patients with Azoospermia or severe Oligozoospermia should be tested to determine etiology and to warn prospective ICSI patients (since these conditions are inheritable).